Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1233 (LINC01233)

Target
LINC01233
Molecular classification
Long non-coding RNA (lncRNA), Non-coding RNA gene, Other (non-protein coding, not receptor, enzyme, transporter, transcription factor)
01

Overview

LINC01233 (long intergenic non-protein coding RNA 1233) is a human long non-coding RNA (lncRNA) gene encoded at locus HGNC:49756, located on chromosome 19p12 (GRCh38/hg38)[1][5][7][9][12]. It is a transcribed RNA molecule that does not encode a protein and instead likely participates in regulatory processes such as gene expression modulation, consistent with broad lncRNA functions[9][11]. LINC01233 is not a receptor, enzyme, transporter, or transcription factor, and is generally not considered a direct therapeutic target[9][11]. The gene is sometimes referenced in cancer research, particularly as part of genomic expression or as a putative modifier, but no drugs or targeted therapies have been described to interact specifically with LINC01233, nor is it listed as a validated biomarker or therapeutic target in clinical sources[9][11][12]. Summary of context and conventions - The gene is correctly named and not misspelled nor incorrectly characterized[3][5]. - Alternative designation XLOC_013014 is a database reference alias[5][7]. - Not classified as a receptor, enzyme, transporter, transcription factor, or any classical druggable molecular class[1][5][7][9]. - Disease associations are mainly correlative/research-based rather than causative or actionable[2][12]. - Safety concerns, mechanisms of drug action, and direct drug interactions do not apply to this lncRNA as of available knowledge[9][11][12].

Other names
XLOC_013014LINC01233
02

Mechanism of action

null

03

Biological functions

Presumed gene regulation via lncRNA-mediated mechanismsNo current evidence for direct biochemical activity such as catalysis or signaling described in available sourcesOther (cellular processes regulated by lncRNAs such as chromatin remodeling, gene expression regulation, may be inferred from broad lncRNA functions)
04

Disease associations

Cancer (notably described in regulatory and expression studies of tumor models, but not as a direct therapeutic target)Other (lncRNAs as biomarkers and modifiers in disease context, may participate in regulatory disease networks)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1233 (LINC01233).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1233 (LINC01233).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call